Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 825 results for "drl"

DRL, Ranbaxy yet to reduce drug prices after July10 order, man...

Following Ranbaxy's refusal to cut prices in anti-diabetic and cardio-vascular segments in compliance with the July 10 NPPA order, Dr Reddy's Laboratories Ltd (DRL) has also refused to cut prices of the 13 specific products covered as per the NPPA ... PharmaBiz, 1 day ago

26 images for drl

4 Traders, 5 days ago
ForceGT, 2 weeks ago, 3 weeks ago
Yahoo!Xtra, 3 weeks ago
Rush Lane, 1 month ago, 1 month ago
Auto Evolution, 1 month ago
4 Traders, 1 month ago
The Hot Hits Live from LA, 1 month ago
Prime Mover Magazine, 1 month ago

Novartis drags DRL to US court for patent violation

Switzerland-based Novartis AG and Novartis Pharmaceuticals Corporation (NPC) have sued Dr Reddy's Laboratories in a the United States' District Court for the District of Delaware for a patent infringement action on the drug Gleevec. The action ...
 Financial Express1 week ago NOVARTIS : Drags drl to us court for patent violation  4 Traders5 days ago Novartis Drags DRL to US Court Over Patent Infringement  New Indian Express1 week ago Teva May Drag DRL to Court in Patent Row  New Indian Express1 month ago

Sun shines in pharma space; M-cap greater than DRL, Lupin, Cipla & Ranbaxy combined

The market capitalisation of Sun Pharmaceuticals exceeded that of Dr Reddy's, Lupin, Cipal and Ranbaxy Laboratories combined on Wednesday, August 20. NEW DELHI: Sun Pharma, which has rallied nearly 50 per cent so far in the year 2014, has beaten its peers in ...
 Economic Times3 weeks ago Sun Pharma's M-cap > DRL + Lupin + Cipla + Ranbaxy  Economic Times3 weeks ago
IBN Live

Sensex, Nifty turn choppy; IT surges, HDFC DRL weak

Hindalco and SBI are still top gainers, followed by Infosys, TCS and HDFC Bank. Coal India, HDFC, Bharti Airtel, Dr Reddy's Labs and Bajaj Auto are among laggards.
 Money Control3 weeks ago Market at new high: Sensex up 138 pts; Reliance, DRL gain  Money Control2 months ago Sensex, Nifty open in green; Bajaj Auto, Hindalco, DRL drag  Money Control2 months ago Sensex up over 100 pts; Nifty firm; Cipla, ONGC, DRL gain  Money Control2 months ago

How Angel Broking is reading Dr Reddy's Q1FY15 earnings

DRL met street expectations with the consolidated net profit rising 52.4 percent on yearly basis to Rs 550 crore driven by strong growth in US sales and also supported by emerging markets, Russia and domestic operations.
 Money Control1 month ago Dr Reddy's Lab Q1 Net Jumps 52%; Above Estimates  NDTV Profit1 month ago DRL rallies over 3% post Q1 results  Economic Times1 month ago Dr Reddy's Q1 Net up 52.49% at Rs 550 cr  INooz1 month ago

DRL under US scanner for packaging violations

Dr Reddy's Laboratories has come under the scanner of the US Department of Justice for alleged violations of some provisions of the Consumer Product Safety Act, involving child-resistant packaging regulations. However, the company has denied the ...
 Financial Express3 weeks ago DRL under scanner for packaging violations  Financial Chronicle3 weeks ago DR REDDY LABORATORIES : Drl under us scanner for packaging violations  4 Traders3 weeks ago Limited-competition products boost Dr Reddy's performance  Sify1 month ago

DRL rises; filing shows US market share gains

A filing with the US Securities and Exchange Commission on Monday shows market share gains in key drugs in the US market, analysts say. DON'T MISS any stories, follow us on Twitter Follow Follow this section for latest news on Stocks in News EmailRSS Have ...
 Economic Times3 weeks ago Dr Reddy's Labs Q1 profit seen up 54% to Rs 557.5 cr: Poll  Moneycontrol.com1 month ago

Cipla gains 3%, Wipro DRL drag; Nifty still below 7800

Cipla is up 3 percent, followed by Tata Steel, Reliance, Coal India and GAIL. Hindalco, Wipro, MM, Dr Reddy's Labs and Sun Pharma are among the laggards.
 Money Control1 month ago Live Market Updates: Nifty above 7550; HDFC, Hindalco, Tata Power gainers  Money Control2 months ago

Accumulate Dr Reddys Labs; target of Rs 2968: Dolat Capital

Dolat Capital`s research report on Dr Reddys Laboratories Dr. Reddy's Labs (DRL) revenues grew at 23.6% YoY to Rs 35.2bn. This was primarily on account of 51.5% growth in North American markets. Revenues from North American markets stood at Rs ...
 Moneycontrol.com1 month ago Hold Dr Reddys Labs; target of Rs 2970: ICICIdirect  Moneycontrol.com1 month ago

DRL to 'perform better than market' this year: CFO

In an interview with CNBC-TV18’s Ekta Batra and Archana Shukla, DRL CFO Saumen Chakraborty discussed the company’s earnings and the outlook going forward.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - drl
Get updated on latest news & your favorite topics right in your inbox!
More     Less